Corrigendum to ‘Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein’ [Pharmacol. Res. 175 (2022) 105975]

• Gamal Eldein Fathy Abd-ellatef,
• Elena Gazzano,
• Ahmed H. El-Desoky,
• Ahmed R. Hamed,
• Joanna Kopecka,
• Dimas Carolina Belisario,
• Costanzo Costamagna,
• Mohamed Assem S. Marie,
• Sohair R. Fahmy,
• Abdel-Hamid Z. Abdel-Hamid,
• Chiara Riganti

Affiliations

Gamal Eldein Fathy Abd-ellatef

Department of Oncology, University of Torino, via Santena 5/bis, 10126 Torino, Italy; Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, 33 El Bohouth St., Dokki, 12622 Giza, Egypt

Elena Gazzano

Department of Oncology, University of Torino, via Santena 5/bis, 10126 Torino, Italy

Ahmed H. El-Desoky

Pharmacognosy Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, 33 El Bohouth St., Dokki, 12622 Giza, Egypt

Ahmed R. Hamed

Chemistry of Medicinal Plants Department & Biology Unit of Central Laboratory, Pharmaceutical and Drug Industries Research Division, National Research Centre, 33 El Bohouth St., Dokki, 12622 Giza, Egypt

Joanna Kopecka

Department of Oncology, University of Torino, via Santena 5/bis, 10126 Torino, Italy

Dimas Carolina Belisario

Department of Oncology, University of Torino, via Santena 5/bis, 10126 Torino, Italy

Costanzo Costamagna

Department of Oncology, University of Torino, via Santena 5/bis, 10126 Torino, Italy

Mohamed Assem S. Marie

Zoology Department, Faculty of Science, Cairo University, Gamaa Street, Giza, Egypt

Sohair R. Fahmy

Zoology Department, Faculty of Science, Cairo University, Gamaa Street, Giza, Egypt

Abdel-Hamid Z. Abdel-Hamid

Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, 33 El Bohouth St., Dokki, 12622 Giza, Egypt

Chiara Riganti

Department of Oncology, University of Torino, via Santena 5/bis, 10126 Torino, Italy; Corresponding author.